The US Department of Health
and Human Services has been
commissioned to convene a Federal
Interagency Steering Committee to
establish a National Action Plan to
focus on adverse drug event (ADE)
prevention, according to a release
from the Joint Commission Journal
on Quality and Patient Safety.
The decision was made to
target three medication classes:
anticoagulants, diabetes agents
(insulin and oral hypoglycemic
agents), and opioids, the report
said.
One measure of the ADE Action
Plan’s success will relate to the
wider dissemination of information
and educational resources.The above article was sent to subscribers in Pharmacy Daily's issue from 18 Aug 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 18 Aug 15
MONTU Group, its subsidiary Alternaleaf Pty Ltd, and their common director Christopher Strauch are facing legal action by the Therapeutic Goods Administration (TGA) in the Federal Court of Australia for alleged unlawful advertising on the effectiveness of their medicinal cannabis products.
AUSTRALIA’S public hospitals are facing their lengthiest wait times on record for planned surgeries, with emergency departments struggling under access blockages, according to the latest annual Public Hospital Report Card by the Australian Medical Association (AMA).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.